National Pension Service Trims Stock Holdings in CVS Health Corporation $CVS

Key Points

• National Pension Service reduced its CVS Health stake by 0.5%, selling 15,397 shares and retaining 3.4 million shares valued at approximately $352.2 million. Institutional investors and hedge funds collectively own 80.66% of CVS.
• Analysts remain broadly bullish, with 22 Buy ratings and one Hold rating, a consensus “Moderate Buy” rating, and an average price target of $107.24.
• CVS reported stronger-than-expected quarterly results, including $2.58 in EPS and $106.1 billion in revenue, while issuing fiscal 2026 EPS guidance of $7.90–$8.10. The company also pays a quarterly dividend of $0.665, representing a 2.8% annualized yield.

National Pension Service cut its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 0.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,404,216 shares of the pharmacy operator's stock after selling 15,397 shares during the period. National Pension Service owned 0.27% of CVS Health worth $352,166,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. Summit Financial Strategies Inc. purchased a new stake in shares of CVS Health in the second quarter valued at about $213,000. Pinnacle Wealth Management Advisory Group LLC grew its holdings in shares of CVS Health by 22.8% during the second quarter. Pinnacle Wealth Management Advisory Group LLC now owns 4,969 shares of the pharmacy operator's stock worth $514,000 after buying an additional 922 shares during the last quarter. NorthRock Partners LLC increased its position in CVS Health by 7.7% in the 2nd quarter. NorthRock Partners LLC now owns 7,569 shares of the pharmacy operator's stock valued at $783,000 after acquiring an additional 538 shares during the period. Community Bank N.A. raised its stake in CVS Health by 21.1% during the 2nd quarter. Community Bank N.A. now owns 4,361 shares of the pharmacy operator's stock valued at $451,000 after acquiring an additional 761 shares during the last quarter. Finally, Maven Securities LTD raised its stake in CVS Health by 205.5% during the 2nd quarter. Maven Securities LTD now owns 27,314 shares of the pharmacy operator's stock valued at $2,830,000 after acquiring an additional 53,214 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on CVS shares. Royal Bank Of Canada lifted their target price on CVS Health from $107.00 to $113.00 and gave the company an "outperform" rating in a research note on Thursday, July 9th. Wall Street Zen raised CVS Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 8th. JPMorgan Chase & Co. lifted their price objective on shares of CVS Health from $111.00 to $118.00 and gave the company an "overweight" rating in a research report on Wednesday, August 12th. Robert W. Baird set a $107.00 price objective on shares of CVS Health in a research report on Thursday, August 6th. Finally, Truist Financial raised their target price on shares of CVS Health from $108.00 to $118.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th. Twenty-two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, CVS Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $107.24.

CVS Health Price Performance

CVS Health stock opened at $95.43 on Thursday. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The business has a fifty day moving average of $100.31 and a two-hundred day moving average of $90.61. The company has a market cap of $122.05 billion, a P/E ratio of 25.25, a price-to-earnings-growth ratio of 0.94 and a beta of 0.59.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts' consensus estimates of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $106.10 billion for the quarter, compared to analysts' expectations of $100.03 billion. During the same period in the prior year, the company posted $1.81 EPS. The business's revenue for the quarter was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date of this dividend was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health's dividend payout ratio (DPR) is 70.37%.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Recent coverage highlighted CVS Health’s improving business performance and financial results. The company’s latest reported quarter included adjusted earnings of $2.58 per share, above the $1.87 analyst consensus, while revenue increased 7.3% year over year. CVS has issued fiscal 2026 earnings guidance of $7.90–$8.10 per share. Wall Street Loves CVS Health Stock Right Now. Should You?
• Positive Sentiment: Zacks identified CVS as a strong momentum stock, while increased investor attention could support near-term trading interest. These assessments are based largely on quantitative and sentiment factors rather than a new company announcement. Here's Why CVS Health Is a Strong Momentum Stock
• Neutral Sentiment: CVS marked the 20th anniversary of its free community health-screening program. A company-commissioned survey found that nearly one in four U.S. adults has delayed contacting a health professional because of access, cost or availability barriers, while one-third were unaware of community screening programs. The initiative may support CVS’s community-health reputation but is unlikely to materially affect near-term earnings. CVS Health Community Health Screening Program
• Negative Sentiment: CVS flagged elevated medical expenses, raising concerns about profit margins and earnings visibility across its managed-care operations. The warning pressured the broader managed-care group and is the clearest near-term reason for weakness in CVS stock. CVS Health Flags Elevated Medical Expenses

CVS Health Company Profile

CVS Health Corporation is an American health care company headquartered in Woonsocket, Rhode Island. Founded in 1963 as Consumer Value Stores, the company has expanded from a chain of retail pharmacies into an integrated health care organization serving consumers, employers, health plans, government programs and health care providers.

CVS Health operates through several major businesses. Its Health Care Benefits segment, anchored by Aetna, provides health insurance products and related services for employers, individuals, Medicare and Medicaid members.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.